ECCRT and IDDI establish partnership for continuous development
Press Release European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning…
News & Events
News & Events
Discover the news and events of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials. We are present at numerous conferences in the world! Let’s meet there!
SCDM 2020 Virtual Conference
September 13, 2020 — September 16, 2020
Join IDDI and the CDM Industry Leaders at SCDM 2020 Virtual Conference Discover how IDDI prepares data for FDA Submission and…
Meet us at the Knowledge For Growth virtual event
September 9, 2020 — September 10, 2020
IDDI will have a virtual booth – Come and e-meet us! Join us and our expert Erik Falvey on September 9…
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors
Highlights We explored relapse-free survival (RFS) as a surrogate for overall survival (OS). We used data from the European Organisation…
IDDI published an editorial on non-inferiority trials
‘Commentary on Bamat et al.’, Clinical Trials 1–2, July 15, 2020 Dr. Everardo Saad, MD and Dr. Marc Buyse, ScD,…
NEWSLETTER APRIL 2020
NEWSLETTER August 2020 CLINICAL TRIAL NEWS ABOUT US BIOSTATISTICAL SERVICES eCLINICAL SERVICES CONTACT US WEBINAR: COMPANION DIAGNOSTICS AND CLINICAL DEVELOPMENT…
Newsletter August 2020
IDDI Member of the Medicon Valley Alliance
Join IDDI at Medicon Valley Alliance MVA Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life…
Assessing Treatment Benefit in Immuno-oncology
Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently…
Statistical Aspects in Adjuvant and Neoadjuvant Trials for Gastrointestinal Cancer in 2020: Focus on Time-To-Event Endpoints
Testing novel agents in gastrointestinal cancer requires continued attention to statistical issues related to endpoints. Purpose of Review: Clinical-trial design,…